Get the Stockscreener App
65.99
0.89%
-0.59
After Hours:
65.99
Edwards Lifesciences Corp stock is traded at $65.99, with a volume of 6.97M.
It is down -0.89% in the last 24 hours and down -5.67% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$66.58
Open:
$66.18
24h Volume:
6.97M
Relative Volume:
1.09
Market Cap:
$39.49B
Revenue:
$6.00B
Net Income/Loss:
$1.47B
P/E Ratio:
28.20
EPS:
2.34
Net Cash Flow:
$551.80M
1W Performance:
-2.03%
1M Performance:
-5.67%
6M Performance:
-30.94%
1Y Performance:
-4.75%
1-Day Range:
$65.20
$66.75
1-Week Range:
$64.54
$67.32
52-Week Range:
$58.93
$96.12
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
Aortic Stenosis Market Is Booming Worldwide 2024-2031 | Edwards - openPR
Edwards Lifesciences' SWOT analysis: stock faces TAVR headwinds, TMTT growth - Investing.com
ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM – Company AnnouncementFT.com - Financial Times
ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM - Quantisnow
MBB Public Markets I LLC Makes New $4.06 Million Investment in Edwards Lifesciences Co. (NYSE:EW) - Defense World
EverSource Wealth Advisors LLC Buys 280 Shares of Edwards Lifesciences Co. (NYSE:EW) - Defense World
APG Asset Management N.V. Purchases 13,832 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Toronto Dominion Bank Sells 60,504 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
APG Asset Management US Inc. Has $15.94 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Point72 Asset Management L.P. Trims Holdings in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Axa S.A. Sells 373,433 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Point72 Europe London LLP Takes Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Bank of Montreal Can Buys 20,240 Shares of Edwards Lifesciences Co. (NYSE:EW) - Defense World
Point72 Europe London LLP Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Federated Hermes Inc. Has $150,000 Holdings in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Xponance Inc. Has $8.53 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by 1832 Asset Management L.P. - Defense World
Mount Yale Investment Advisors LLC Sells 609 Shares of Edwards Lifesciences Co. (NYSE:EW) - Defense World
Edwards Lifesciences Co. (NYSE:EW) Stake Increased by Frank Rimerman Advisors LLC - Defense World
Benjamin F. Edwards & Company Inc. Boosts Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Xponance Inc. Cuts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Epoch Investment Partners Inc. Raises Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Fidelis Capital Partners LLC Grows Stake in Edwards Lifesciences Co. (NYSE:EW) - Defense World
King Luther Capital Management Corp Has $427,000 Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Itau Unibanco Holding S.A. Invests $1.92 Million in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Shareholders Are Optimistic That Edwards Lifesciences (NYSE:EW) Will Multiply In Value - Yahoo Finance
Intech Investment Management LLC Cuts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Skandinaviska Enskilda Banken AB publ Has $43.68 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EWTX Yields Over 300% Returns, ADMA Records 200% GainsDid You Strike While The Iron Is Hot? - RTTNews
Middleton & Co. Inc. MA Sells 200 Shares of Edwards Lifesciences Co. (NYSE:EW) - Defense World
Edwards Lifesciences Co. (NYSE:EW) Stock Holdings Lifted by Vanguard Personalized Indexing Management LLC - Defense World
Will Edwards Lifesciences Corp (EW) meet earnings estimates this quarter? - US Post News
Financial Health Check: Examining Edwards Lifesciences Corp (EW)’s Key Ratios - The Dwinnex
Axxcess Wealth Management LLC Has $1.27 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Brown Brothers Harriman & Co. Trims Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
Edwards Lifesciences Co. (NYSE:EW) Shares Purchased by J.W. Cole Advisors Inc. - Defense World
Edwards Lifesciences (NYSE:EW) Lowered to Hold at Jefferies Financial Group - Defense World
Get in on Edwards Lifesciences Corp’s (EW) buy-in window today! - SETE News
Jefferies downgrades Edwards Lifesciences stock rating amid TAVR growth concerns - Investing.com India
Jefferies downgrades Edwards Lifesciences stock rating amid TAVR growth concerns - Investing.com
Emmaus Life Sciences director buys $800 in company stock By Investing.com - Investing.com UK
Edwards Lifesciences: Solvable Problems Offer Excellent Opportunities (NYSE:EW) - Seeking Alpha
Edwards Lifesciences (NYSE:EW) Cut to Hold at Jefferies Financial Group - MarketBeat
Edwards Lifesciences downgraded at Jefferies on lower TAVR growth - Seeking Alpha
Edwards launches Sapien 3 valve with Alterra prestent in Europe - Mass Device
Edwards Launches SAPIEN 3 With Alterra Prestent in Europe for Transcatheter Pulmonic Valve Implantation - Via Ritzau
(EW) On The My Stocks Page - Stock Traders Daily
Edwards Lifesciences gains amid takeover speculation - Seeking Alpha
Edwards Lifesciences Corp (EW) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.02%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):